Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20491470 | 0.92 | NPC1 (0.52) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL4894905 | 0.90 | ALDH1A1 (0.46) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL31277051 | 0.90 | ALDH1A1 (0.64) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL14447667 | 0.90 | ALDH1A1 (0.64) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL27318412 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL6906334 | 0.86 | CYP1A2 (0.48) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL29737067 | 0.86 | CYP1A2 (0.48) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL21758076 | 0.85 | RAB9A (0.52) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL7195015 | 0.84 | GPR84 (0.60) | ALDH1A1TSHRATMNPSR1NPC1 | |
| SCHEMBL598903 | 0.84 | TSHR (0.58) | ALDH1A1TSHRATMNPSR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122133-A1 | Selective Transition Metal Catalyzed Deuterium Incorporation Into Alkyne and Alkene Functionalities | MARQUETTE UNIVERSITY | 2025-04-17 | — | — | US | disclosed |
| CN-115621528-B | Pre-lithiation method of battery cathode, pre-lithiated cathode plate and lithium ion battery | 比亚迪股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-114195611-B | Synthesis method of diaryl methane compound | 合肥工业大学 | 2024-05-28 | — | — | CN | disclosed |
| EP-4237144-A1 | SELECTIVE TRANSITION METAL CATALYZED DEUTERIUM INCORPORATION INTO ALKYNE AND ALKENE FUNCTIONALITIES | Marquette University (US) | 2023-09-06 | — | — | EP | disclosed |
| CN-115621528-A | Pre-lithiation method of battery negative electrode, pre-lithiation negative electrode sheet and lithium ion battery | 比亚迪股份有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-01-05 | — | — | US | disclosed |
| EP-4105222-A1 | IRIDIUM COMPLEX COMPOUND, IRIDIUM COMPLEX COMPOUND-CONTAINING COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND PRODUCTION METHOD THEREFOR, ORGANIC EL DISPLAY DEVICE, AND ORGANIC EL LIGHTING DEVICE | Mitsubishi Chemical Corporation (JP) | 2022-12-21 | — | — | EP | disclosed |
| CN-115135662-A | Iridium complex compound, composition containing iridium complex compound, organic electroluminescent element and method for producing same, organic EL display device, and organic EL lighting device | 三菱化学株式会社 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022094420-A1 | SELECTIVE TRANSITION METAL CATALYZED DEUTERIUM INCORPORATION INTO ALKYNE AND ALKENE FUNCTIONALITIES | MARQUETTE UNIVERSITY (US) | 2022-05-05 | — | — | WO | disclosed |
| US-5300642-A | α, α-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| EP-0311010-B1 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | DU PONT MERCK PHARMA (US) | 1994-02-02 | — | — | EP | disclosed |
| EP-0532054-A1 | Process for preparing alpha,alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5191132-A | CYCLOPENTADIENE TYPE COMPOUNDS AND METHOD FOR MAKING | PHILLIPS PETROLEUM COMPANY (US) | 1993-03-02 | — | — | US | disclosed |
| CN-1068829-A | Organometallic fluorenyl compounds and preparation thereof and application | PHILLIPS PETROLEUM CO (US) | 1993-02-10 | — | — | CN | disclosed |
| EP-0524624-A2 | Organometallic fluorenyl compounds, preparation, and use | PHILLIPS PETROLEUM COMPANY (US) | 1993-01-27 | — | — | EP | disclosed |
| CN-1066440-A | Cyclopeutadiene type compounds and preparation method thereof | PHILLIPS PETROLEUM CO (US) | 1992-11-25 | — | — | CN | disclosed |
| EP-0512554-A2 | Cyclopetadiene type compounds and method for making | PHILLIPS PETROLEUM COMPANY (US) | 1992-11-11 | — | — | EP | disclosed |
| EP-0311010-A2 | Alpha,Alpha-disubstituted aromatics and heteroaromatics as cognition enhancers | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1989-04-12 | — | — | EP | disclosed |
| US-3939276-A | ANTHRAQUINONES, ASTHMA, ANTIALLERGENS | BURROUGHS WELLCOME CO. (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122133-A1 | Selective Transition Metal Catalyzed Deuterium Incorporation Into Alkyne and Alkene Functionalities | HDHD5, DDT, AHR | ALDH1A1 782/4885TSHR 2408/4885ATM 3079/4885 |
| US-20230002428-A1 | Iridium Complex Compound, Iridium-Complex-Compound-Containing Composition, Organic Electroluminescent Element and Method for Producing Same, Organic EL Display Device, and Organic EL Illuminator | INF2, EMC2, DRD4 | ALDH1A1 989/4885TSHR 1733/4885ATM 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.